---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-010594"
form_type: "8-K"
ticker: "DARE"
cik: "0001401914"
company_name: "Dare Bioscience, Inc."
filed_at: "2026-03-17T23:59:59+00:00"
generated_at: "2026-05-15T10:19:40.499048+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Daré Bioscience closes $215K Regulation A offering of Series A Preferred Stock and warrants

## Summary
- Issued 43,050 Investor Units at $5.00/unit; each unit contains one share of Series A Convertible Preferred and two common stock purchase warrants.
- Total gross proceeds of approximately $215,250; warrants exercisable for up to 86,100 shares of common stock.
- Offering qualified by SEC on January 5, 2026 under Regulation A; terms previously reported in Form 8-K filed January 29, 2026.
- Proceeds provide additional working capital for the company's development programs.

## SEC filing metadata
- accession: 0001493152-26-010594
- form_type: 8-K
- ticker: DARE
- cik: 0001401914
- company_name: Dare Bioscience, Inc.
- filed_at: 2026-03-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401914/000149315226010594/0001493152-26-010594-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401914/000149315226010594/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-010594
- JSON: https://secwatch.observer/filing/0001493152-26-010594.json
- Plain text: https://secwatch.observer/filing/0001493152-26-010594.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.